OXY
41
9
HP
48
2
NOC
45
-2
VTR
70
-5
VNO
49
3
PPL
47
-5
EMN
53
3
WM
48
-2
GPC
53
-4
NSC
57
-3
EXPE
81
-2
BEN
48
2
XOM
50
6
APA
57
-2
DE
40
-2
MU
68
2
ILMN
70
2
EXPD
35
-2
MCK
60
-2
MLM
60
-6
OXY
41
9
HP
48
2
NOC
45
-2
VTR
70
-5
VNO
49
3
PPL
47
-5
EMN
53
3
WM
48
-2
GPC
53
-4
NSC
57
-3
EXPE
81
-2
BEN
48
2
XOM
50
6
APA
57
-2
DE
40
-2
MU
68
2
ILMN
70
2
EXPD
35
-2
MCK
60
-2
MLM
60
-6
Financhill
Back

Diebold Nixdorf, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
76

DBD
Diebold Nixdorf, Inc.

Last Price:
$67.11
Seasonality Move:
11.65%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
76
Diebold Nixdorf, Inc. (DBD) is a Buy

Is Diebold Nixdorf, Inc. a Buy, Sell or Hold?

  • The current Diebold Nixdorf, Inc. [DBD] share price is $65.60. The Score for DBD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • DBD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

DBD Stock Price Chart

What is Diebold Nixdorf, Inc.'s stock price today?

  • The Diebold Nixdorf, Inc. share price today is $65.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBD is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

DBD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.32 Buy
Relative Strength Index (14 RSI): 59.37 Buy
Chaikin Money Flow: -339468 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.65 - 66.13) Buy
Bollinger Bands (100): (56.97 - 63.13) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

DBD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.35 Buy
20-day SMA: 64.13 Buy
50-day SMA: 60.72 Buy
200-day SMA: 53.81 Buy
8-day EMA: 65.13 Buy
20-day EMA: 63.97 Buy
50-day EMA: 61.85 Buy
200-day EMA: 55.23 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Diebold Nixdorf, Inc. Earnings Growth & DBD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.89 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Diebold Nixdorf, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):